Skip to main content

Peer Review reports

From: Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data

Original Submission
11 Mar 2019 Submitted Original manuscript
25 Apr 2019 Reviewed Reviewer Report - Adam Brufsky
5 Jul 2019 Reviewed Reviewer Report - Reviewer 2
9 Aug 2019 Author responded Author comments - Sabine Schmid
Resubmission - Version 2
9 Aug 2019 Submitted Manuscript version 2
15 Aug 2019 Reviewed Reviewer Report - Adam Brufsky
26 Aug 2019 Author responded Author comments - Sabine Schmid
Resubmission - Version 3
26 Aug 2019 Submitted Manuscript version 3
27 Aug 2019 Author responded Author comments - Sabine Schmid
Resubmission - Version 4
27 Aug 2019 Submitted Manuscript version 4
Publishing
29 Aug 2019 Editorially accepted
10 Sep 2019 Article published 10.1186/s12885-019-6105-3

You can find further information about peer review here.

Back to article page